COVID-19 and diabetes mellitus patients
- 22 January 2022
- journal article
- Published by Peertechz Publications Private Limited in Global Journal of Obesity, Diabetes and Metabolic Syndrome
- Vol. 9 (1), 007-010
- https://doi.org/10.17352/2455-8583.000055
Abstract
Coronavirus (COVID-19) is an encapsulated virus with a self-positive-sense RNA genome that is proven to cause respiratory disease in humans. Coronaviruses (COVID-19) are a type of virus that infects the respiratory tract [1]. In most immunocompetent individuals, infection with human COVID-19 results in a moderate upper respiratory infection in the majority of cases.Keywords
This publication has 19 references indexed in Scilit:
- Pulmonary Embolism in Patients With COVID-19Journal of the American College of Cardiology, 2020
- Practical recommendations for the management of diabetes in patients with COVID-19The Lancet Diabetes & Endocrinology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysisTravel Medicine and Infectious Disease, 2020
- Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysisJournal of Medical Virology, 2020
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVNature Communications, 2020
- From SARS to MERS, Thrusting Coronaviruses into the SpotlightViruses, 2019
- High Prevalence of Asthma in Elderly Women: Findings From a Korean National Health Database and Adult Asthma CohortAllergy, Asthma & Immunology Research, 2018
- Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARSDiabetic Medicine, 2006
- Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003The Lancet, 2003